Taja Barber
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Generation of TWO iPSC lines (CRICKi009-A; CRICKi010-A) from patients with type 1 von Hippel-Lindau (VHL) and histopathologically confirmed renal cell carcinoma (RCC).
Journal: Stem cell research
Published: April 24, 2024
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Journal: Cell reports. Medicine
Published: June 06, 2022
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Journal: Cancer cell
Published: April 12, 2022
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Journal: Cancer cell
Published: December 30, 2021
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Journal: Lancet (London, England)
Published: December 29, 2021
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Journal: Nature cancer
Published: December 24, 2021
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Journal: Nature cancer
Published: August 18, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026